OA08166A - New 2-amino-oxazolines and their process for obtaining. - Google Patents
New 2-amino-oxazolines and their process for obtaining.Info
- Publication number
- OA08166A OA08166A OA58630A OA58630A OA08166A OA 08166 A OA08166 A OA 08166A OA 58630 A OA58630 A OA 58630A OA 58630 A OA58630 A OA 58630A OA 08166 A OA08166 A OA 08166A
- Authority
- OA
- OAPI
- Prior art keywords
- radical
- lower alkyl
- hydrogen
- equal
- denotes
- Prior art date
Links
- YAXGBZDYGZBRBQ-UHFFFAOYSA-N 4,5-dihydro-1,3-oxazol-2-amine Chemical class NC1=NCCO1 YAXGBZDYGZBRBQ-UHFFFAOYSA-N 0.000 title abstract 2
- -1 alkyl radical Chemical class 0.000 abstract 11
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 5
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000007524 organic acids Chemical class 0.000 abstract 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 abstract 1
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical compound F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000005530 alkylenedioxy group Chemical group 0.000 abstract 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 1
- 230000001430 anti-depressive effect Effects 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical compound O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The subject matter is specifically the 2-aminooxazolines of general formula <IMAGE> in which Z is hydrogen, a halogen atom, a lower alkyl radical, a lower alkoxy radical, a trifluoromethyl radical, a trifluoromethoxy, cyano, nitro or carboxamido radical, a lower alkenyl radical, a (lower alkyl)thio radical, an alkylenedioxy group, a cycloalkenyl or lower cycloalkyl radical X denotes oxygen, sulphur, an imino radical of formula <2bL>N-R1- in which R1 is hydrogen or a lower alkyl radical or an acyl radical derived from a carboxylic or sulphonic organic acid - a methylene radical or a direct bond. Y denotes hydrogen, a lower alkyl radical, an unsubstituted or substituted phenyl radical, a hydroxyl or a phenoxy radical Y' denotes hydrogen or else Y and Y' together form the oxygen of a carbonyl group or else Y forms with the adjacent phenyl radical, when n is equal to zero, a saturated or unsaturated bicyclic, homocyclic or heterocyclic structure, R3 and R4, which are similar or different, denote hydrogen, a lower alkyl, lower alkenyl, lower aralkyl or (heteroaryl) lower alkyl, aryl, alkoxycarbonyl, aminocarbonyl or acyl radical derived from a carboxylic organic acid containing from 1 to 10 carbon atoms or an amino radical, or else R3 and R4 form with the nitrogen atom to which they are bonded the alkylene chain of a nitrogenous heterocyclic structure optionally interrupted by one or two other heteroatoms R denotes a hydrogen, a lower alkyl radical or an optionally substituted phenyl radical n is equal to zero or 1 n1 is equal to 0, 1 or 2 and p is equal to 1, 2 or 3. The compounds according to the invention may be converted into salts by addition of an inorganic or organic acid, preferably a therapeutically compatible acid. They are used as active principle in antidepressant or antihypertensive pharmaceutical compositions.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH326384 | 1984-07-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA08166A true OA08166A (en) | 1987-03-31 |
Family
ID=4252197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA58630A OA08166A (en) | 1984-07-05 | 1985-07-05 | New 2-amino-oxazolines and their process for obtaining. |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0167459B1 (en) |
| JP (1) | JPS61155375A (en) |
| AT (1) | ATE69222T1 (en) |
| AU (1) | AU579872B2 (en) |
| CA (1) | CA1258040A (en) |
| DD (1) | DD240015A5 (en) |
| DE (1) | DE3584584D1 (en) |
| DK (1) | DK302185A (en) |
| ES (2) | ES8700853A1 (en) |
| HU (1) | HU193333B (en) |
| MA (1) | MA20480A1 (en) |
| OA (1) | OA08166A (en) |
| PL (1) | PL254398A1 (en) |
| PT (1) | PT80779B (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2632860A1 (en) * | 1988-06-21 | 1989-12-22 | Rolland Sa A | Novel antidepressant medicaments and pharmaceutical compositions containing them |
| US5948820A (en) * | 1994-08-22 | 1999-09-07 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzene compound and pharmaceutical use thereof |
| DE69524962T4 (en) * | 1994-08-22 | 2003-08-28 | Mitsubishi Pharma Corp., Osaka | BENZENE DERIVATIVES AND THEIR MEDICAL USE |
| MXPA04006709A (en) | 2002-01-11 | 2004-10-04 | Sankyo Co | Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these. |
| KR20110136901A (en) | 2004-02-24 | 2011-12-21 | 상꾜 가부시키가이샤 | Amino alcohol compounds |
| CA2675221C (en) * | 2007-02-02 | 2016-02-23 | F. Hoffmann-La Roche Ag | Novel 2-aminooxazolines as taar1 ligands |
| MX2009008465A (en) | 2007-02-15 | 2009-08-20 | Hoffmann La Roche | 2-aminooxazolines as taar1 ligands. |
| CN101952260B (en) * | 2008-02-18 | 2013-02-13 | 弗·哈夫曼-拉罗切有限公司 | 4, 5-dihydro-oxazol-2-yl amine derivatives |
| US8242153B2 (en) | 2008-07-24 | 2012-08-14 | Hoffmann-La Roche Inc. | 4,5-dihydro-oxazol-2YL derivatives |
| ES2556633T3 (en) * | 2008-07-24 | 2016-01-19 | F. Hoffmann-La Roche Ag | 4,5-Dihydro-oxazol-2-yl derivatives |
| US8354441B2 (en) | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| US8673950B2 (en) | 2010-11-02 | 2014-03-18 | Hoffmann-Laroche Inc. | Dihydrooxazol-2-amine derivatives |
| RS60825B1 (en) | 2016-03-17 | 2020-10-30 | Hoffmann La Roche | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2448M (en) * | 1963-02-27 | 1964-04-06 | Mcneilab Inc | Compound of the class of 2-amino-5-aryl-oxazolines and pharmaceutical compositions containing it. |
| FR2444673A1 (en) * | 1978-12-20 | 1980-07-18 | Science Union & Cie | NOVEL TRIFLUOROETHYLAMINES, PROCESSES FOR OBTAINING SAME AND THEIR USE AS MEDICAMENTS |
| US4647557A (en) * | 1982-12-28 | 1987-03-03 | Gerard Moinet | Novel heterocyclic derivatives bearing an amino radical, processes for their production and the pharmaceutical compositions containing them |
-
1985
- 1985-07-03 DK DK302185A patent/DK302185A/en not_active Application Discontinuation
- 1985-07-04 MA MA20705A patent/MA20480A1/en unknown
- 1985-07-04 DE DE8585401360T patent/DE3584584D1/en not_active Expired - Fee Related
- 1985-07-04 AT AT85401360T patent/ATE69222T1/en not_active IP Right Cessation
- 1985-07-04 EP EP85401360A patent/EP0167459B1/en not_active Expired - Lifetime
- 1985-07-04 DD DD85278275A patent/DD240015A5/en unknown
- 1985-07-05 ES ES544926A patent/ES8700853A1/en not_active Expired
- 1985-07-05 JP JP60148123A patent/JPS61155375A/en active Pending
- 1985-07-05 PT PT80779A patent/PT80779B/en unknown
- 1985-07-05 HU HU852621A patent/HU193333B/en unknown
- 1985-07-05 PL PL25439885A patent/PL254398A1/en unknown
- 1985-07-05 OA OA58630A patent/OA08166A/en unknown
- 1985-07-05 CA CA000486391A patent/CA1258040A/en not_active Expired
- 1985-07-08 AU AU44681/85A patent/AU579872B2/en not_active Expired - Fee Related
-
1986
- 1986-03-15 ES ES553058A patent/ES8705364A1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61155375A (en) | 1986-07-15 |
| ATE69222T1 (en) | 1991-11-15 |
| PT80779B (en) | 1987-01-12 |
| HUT38918A (en) | 1986-07-28 |
| AU579872B2 (en) | 1988-12-15 |
| AU4468185A (en) | 1986-01-30 |
| ES553058A0 (en) | 1987-05-01 |
| ES544926A0 (en) | 1986-10-16 |
| EP0167459A3 (en) | 1987-02-25 |
| PT80779A (en) | 1985-08-01 |
| DD240015A5 (en) | 1986-10-15 |
| DE3584584D1 (en) | 1991-12-12 |
| EP0167459A2 (en) | 1986-01-08 |
| CA1258040A (en) | 1989-08-01 |
| ES8700853A1 (en) | 1986-10-16 |
| PL254398A1 (en) | 1986-06-17 |
| HU193333B (en) | 1987-09-28 |
| EP0167459B1 (en) | 1991-11-06 |
| MA20480A1 (en) | 1986-04-01 |
| DK302185A (en) | 1986-01-06 |
| ES8705364A1 (en) | 1987-05-01 |
| DK302185D0 (en) | 1985-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU91196I2 (en) | Picoxystrobin and its pharmaceutically acceptable derivatives (ACANTO). | |
| AU579872B2 (en) | 2-amino-4-substituted oxazolines | |
| FI892787A0 (en) | Analog method for the preparation of therapeutically useful 1-indolylalkyl-4- (substituted pyridinyl) piperazines | |
| EA200100755A1 (en) | 4-OXO-1,4-DIHYDRO-3-QUINOLINKARBOXAMIDES AS ANTI-VIRUS AGENTS | |
| BG96978A (en) | DERIVATIVES AND ANALOGS OF 2-DESOXY-2,3-DIDEHYDRO-N- ACETYLNEURAMINIC ACID AND THEIR USE AS ANTIVIRAL AGENTS | |
| FI904327A0 (en) | N-SUBSTITUERAD-4-PYRIMIDINAMINER OCH -PYRIMIDINDIAMINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING SOM LAEKEMEDEL. | |
| NO854671L (en) | PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE SUBSTITUTED IMIDAZOLS. | |
| ATE128975T1 (en) | UREA DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICATIONS CONTAINING SAME. | |
| MX9203163A (en) | MORPHOLINOETHYL ESTERS OF MYCOPHENOLIC ACID AND COMPOSITIONS. | |
| PT94297A (en) | N-HETERO-ARYL-PURIN-6-AMINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| DE60105610D1 (en) | Pyrazinonderivate | |
| ES8800936A1 (en) | Tricyclic pyridone derivatives. | |
| ATE14312T1 (en) | PHENOLESTERS. | |
| ES2262504T3 (en) | DERIVATIVES OF THE PYROGLUTAMIC ACID AND RELATED COMPOUNDS THAT INHIBIT THE ADHESION OF LEUKOCYTES THROUGH THE VLA-4. | |
| PE20000645A1 (en) | DERIVATIVES OF 3- (2-OXO- [1,3`] BIPYRROLIDINYL-3-ILIDENMETIL) -CEPHEMS | |
| BR8900317A (en) | PROCESS FOR THE PREPARATION OF HERBICIDIC COMPOUNDS AND HERBICIDIC COMPOUNDS | |
| FI875251A0 (en) | FOERFARANDE FOER FRAMSTAELLNING AV 2-ARYLPROPIONSYROR. | |
| DE3769451D1 (en) | INDAN DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THE INTERIM PRODUCTS OBTAINED, THEIR USE AS MEDICINAL PRODUCTS AND COMPOSITIONS CONTAINING THE SAME. | |
| ATE201877T1 (en) | CONDENSED HETEROCYCLIC GLUTAMINE ACID DERIVATIVES AS ANTIPROLIFERATIVE AGENTS | |
| PT88338A (en) | PROCESS FOR THE MANUFACTURE OF IMIDAZO-BENZODIAZEPINES AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| ES8800938A1 (en) | PROCEDURE FOR PREPARING BIOLOGICALLY ACTIVE BERBANIC DERIVATIVES. | |
| ATE5724T1 (en) | GUANIDIN COMPOUNDS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM. | |
| DK0377532T3 (en) | thioformamide | |
| ATE73801T1 (en) | HETEROCYCLIC OXOPHTHALAZINYLACETIC ACID. |